The Clinical Effectiveness of Hydroxylated Polymethoxy Flavones Solid Dispersion as a Dressing Material for Palatal Graft Donor Sites
| Registry | NCT05814003, acronym RCT |
|---|---|
| Status | Unknown |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 30 (Estimated) |
| Sponsor | Assiut University (Other) |
| Conditions | Soft Tissue Infections, Gingival Recession |
| Interventions | hydroxylate flavones solid dispersion application, Placebo (Drug, other) |
| Dates | start 2023-04-20 (estimated), primary completion 2023-05-20 (estimated), completion 2023-05-20 (estimated), first posted 2023-04-14, last updated 2023-04-14 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
All trials for Soft Tissue Infections All trials for Gingival Recession All trials of hydroxylate flavones solid dispersion application All trials of Placebo
Free gingival grafting surgeries require palatal grafts harvesting from the patient own palates . The donor sites pain , infection and retarded healing by secondary intension are the complication .
After the preparation and characterization of the solid dispersion of hydroxylated methoxy flavones, free gingival grafting surgeries require palatal grafts harvesting from the patient own palates . The donor sites pain , infection and retarded healing by secondary intension are the complications ; the aim of the study is to assess the analgesic , anti inflammatory effects of hydroxylated methoxy flavones.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| hydroxylate flavones | Experimental | Drug: hydroxylate flavones solid dispersion application; Other: Placebo | flavonoids mainly derived from citrus peel and have numerous strong biological activities, including anti-inflammatory , antioxidant , antimicrobial , and anticancer |
| alveogyl | Active comparator | Drug: hydroxylate flavones solid dispersion application; Other: Placebo | ALVOGYL is a brown fibrous paste which contains per 100 g the following active ingredients : 25.70 g of butamben, 15.80 g of iodoform and 13.70 g of eugenol. |
| stent | Placebo comparator | Drug: hydroxylate flavones solid dispersion application | acrylic resin material used to cover denuded soft tissues |
Sex: All, ages: 18 Years to 65 Years, accepts healthy volunteers
Inclusion Criteria: * insufficient zone of keratinized gingiva recession of the gingiva non smokers free from systemic disorders Exclusion Criteria: * smokers insufficient palatal donor sits un realistic expectations
| Facility | City | Country | Status |
|---|---|---|---|
| Assiut University | Asyut | Egypt |